-+ 0.00%
-+ 0.00%
-+ 0.00%

GSK: NUCALA (MEPOLIZUMAB) RECEIVES POSITIVE REIMBURSEMENT RECOMMENDATION FROM CDA-AMC FOR ADULTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Reuters·08/18/2026 14:22:52

Please log in to view news